The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report), retaining the ...

Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this ...

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug Black Diamond Therapeutics reports promising ...

Black Diamond Therapeutics (NASDAQ ... then it might be able to do so at a higher stock price. Of course, that's if the data updates and FDA meeting go well in terms of further development of ...

In a report released today, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Black Diamond Therapeutics (BDTX – Research ...